U.S. Markets close in 52 mins
  • S&P 500

    -6.04 (-0.17%)
  • Dow 30

    -105.68 (-0.36%)
  • Nasdaq

    +21.32 (+0.20%)
  • Russell 2000

    +7.88 (+0.48%)
  • Crude Oil

    +2.10 (+2.74%)
  • Gold

    +6.20 (+0.38%)
  • Silver

    -0.03 (-0.16%)

    -0.0013 (-0.1344%)
  • 10-Yr Bond

    +0.0830 (+2.14%)
  • Vix

    +0.54 (+1.67%)

    +0.0043 (+0.4055%)

    +0.1500 (+0.1037%)

    -64.04 (-0.33%)
  • CMC Crypto 200

    -20.59 (-4.49%)
  • FTSE 100

    -36.36 (-0.52%)
  • Nikkei 225

    +140.32 (+0.53%)

Will Weakness in Dynavax Technologies Corporation's (NASDAQ:DVAX) Stock Prove Temporary Given Strong Fundamentals?

·3 min read

With its stock down 33% over the past month, it is easy to disregard Dynavax Technologies (NASDAQ:DVAX). However, a closer look at its sound financials might cause you to think again. Given that fundamentals usually drive long-term market outcomes, the company is worth looking at. In this article, we decided to focus on Dynavax Technologies' ROE.

Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors’ money. In short, ROE shows the profit each dollar generates with respect to its shareholder investments.

See our latest analysis for Dynavax Technologies

How Do You Calculate Return On Equity?

Return on equity can be calculated by using the formula:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

So, based on the above formula, the ROE for Dynavax Technologies is:

55% = US$233m ÷ US$423m (Based on the trailing twelve months to June 2022).

The 'return' is the income the business earned over the last year. Another way to think of that is that for every $1 worth of equity, the company was able to earn $0.55 in profit.

What Is The Relationship Between ROE And Earnings Growth?

So far, we've learned that ROE is a measure of a company's profitability. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don't have the same features.

A Side By Side comparison of Dynavax Technologies' Earnings Growth And 55% ROE

To begin with, Dynavax Technologies has a pretty high ROE which is interesting. Secondly, even when compared to the industry average of 23% the company's ROE is quite impressive. Under the circumstances, Dynavax Technologies' considerable five year net income growth of 39% was to be expected.

Next, on comparing with the industry net income growth, we found that Dynavax Technologies' growth is quite high when compared to the industry average growth of 21% in the same period, which is great to see.


The basis for attaching value to a company is, to a great extent, tied to its earnings growth. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. If you're wondering about Dynavax Technologies''s valuation, check out this gauge of its price-to-earnings ratio, as compared to its industry.

Is Dynavax Technologies Efficiently Re-investing Its Profits?

Dynavax Technologies doesn't pay any dividend to its shareholders, meaning that the company has been reinvesting all of its profits into the business. This is likely what's driving the high earnings growth number discussed above.


Overall, we are quite pleased with Dynavax Technologies' performance. In particular, it's great to see that the company is investing heavily into its business and along with a high rate of return, that has resulted in a sizeable growth in its earnings. That being so, according to the latest industry analyst forecasts, the company's earnings are expected to shrink in the future. To know more about the latest analysts predictions for the company, check out this visualization of analyst forecasts for the company.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here